The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea
Primary Purpose
Primary Dysmenorrhea
Status
Completed
Phase
Phase 4
Locations
Thailand
Study Type
Interventional
Intervention
Ayurved Siriraj Prasaplai with or without mefenamic acid
Placebo with or without mefenamic acid
Sponsored by
About this trial
This is an interventional treatment trial for Primary Dysmenorrhea focused on measuring Ayurved Siriraj Prasaplai, primary dysmenorrhea
Eligibility Criteria
Inclusion Criteria:
- Woman who is diagnosed of primary dysmenorrhea.
- Woman who has regular menstruation.
- woman who has numeric rating score for pain during menstruation (dysmenorrhea) more than score 5 and continuous for 3 menstrual cycle.
- Woman who want to participate in this study.
Exclusion Criteria:
- Woman who has allergic history for herbal or other components in Ayurved Siriraj Prasaplai drug.
- Woman who has hormonal contraception.
- Woman who has other diseases which is caused of abdominal pain.
- Breast feeding woman
Sites / Locations
- Gynecologic Endocrinology Unit, Department of Obstetric and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Ayurved Siriraj Prasaplai
placebo
Arm Description
Outcomes
Primary Outcome Measures
Pain score between experimental and placebo group
Compare pain score by using numeric rating scale (NRS) between the group of women who recieve Ayurved Siriraj Prasaplai with placebo group.
Secondary Outcome Measures
To study about adverse effects of Ayurved Siriraj Prasaplai
To study about adverse effects such as skin rash, nausea vomitting, palpitation, jaundice, hypersensitivity symptoms during treatment with Ayurved Siriraj Prasaplai or placebo.
Number of mefenamic acid for breaking pain during study of both group
During experiment if participant couldn't tolerate the pain which be treated with Ayurved Siriraj Prasaplai or placebo, they could have breaking pain(rescue treatment) with mefenamic acid. Then the participant have to record the number of mefenamic acid and timing which they used in record form.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01598012
Brief Title
The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea
Official Title
The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea
Study Type
Interventional
2. Study Status
Record Verification Date
August 2013
Overall Recruitment Status
Completed
Study Start Date
December 2011 (undefined)
Primary Completion Date
July 2013 (Actual)
Study Completion Date
August 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mahidol University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Ayurved Siriraj Prasaplai is a Thai traditional herbal drug for pain treatment. Mostly it was used for antipain during menstruation or dysmenorrhea. This drug has been described by alternative medical doctor for treatment of primary dysmenorrhea for more than 10 years and showed clinical satisfied response. From review about this agent, it does not have clinical trial to prove its efficacy. So the author produce this research to study in efficacy of Ayurved Siriraj Prasaplai.
Detailed Description
The participants were allocated in the study by block randomization and double blind. In experiment-group was treated with Ayurved Siriraj Prasaplai and control-group was treated with placebo (non-active agent). Both of drug was made in the same appearance of capsule (size and color). The participants have to start the drug when they have menstruation after that the dosage is 2 capsules for 3 times per day (after-meal) continue to 3 days. The participant have to record pain score (minimal/maximal/mean score) and multidimensional score in daily card, side effect and satisfaction. If the participant couldn't tolerate the pain, they could break the pain with mefenamic acid. They have record number of mefenamic acid which they used too. This study evaluate in only one cycle. After complete record, the participant come back to investigator for sending the report.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Primary Dysmenorrhea
Keywords
Ayurved Siriraj Prasaplai, primary dysmenorrhea
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Ayurved Siriraj Prasaplai
Arm Type
Experimental
Arm Title
placebo
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Ayurved Siriraj Prasaplai with or without mefenamic acid
Other Intervention Name(s)
Ponstan
Intervention Description
Prasaplai in capsule, 2 cap three times a day for 3 days. Mefenamic acid 500 mg prn for severe pain (as rescue medication)
Intervention Type
Drug
Intervention Name(s)
Placebo with or without mefenamic acid
Other Intervention Name(s)
Ponstan
Intervention Description
Placebo in capsule (physically identical appearance as Prasaplai) 2 cap three times a day for 3 days. Mefenamic acid 500 mg prn for severe pain, every 6 hours (rescue medication)
Primary Outcome Measure Information:
Title
Pain score between experimental and placebo group
Description
Compare pain score by using numeric rating scale (NRS) between the group of women who recieve Ayurved Siriraj Prasaplai with placebo group.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
To study about adverse effects of Ayurved Siriraj Prasaplai
Description
To study about adverse effects such as skin rash, nausea vomitting, palpitation, jaundice, hypersensitivity symptoms during treatment with Ayurved Siriraj Prasaplai or placebo.
Time Frame
1 year
Title
Number of mefenamic acid for breaking pain during study of both group
Description
During experiment if participant couldn't tolerate the pain which be treated with Ayurved Siriraj Prasaplai or placebo, they could have breaking pain(rescue treatment) with mefenamic acid. Then the participant have to record the number of mefenamic acid and timing which they used in record form.
Time Frame
1 year
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Woman who is diagnosed of primary dysmenorrhea.
Woman who has regular menstruation.
woman who has numeric rating score for pain during menstruation (dysmenorrhea) more than score 5 and continuous for 3 menstrual cycle.
Woman who want to participate in this study.
Exclusion Criteria:
Woman who has allergic history for herbal or other components in Ayurved Siriraj Prasaplai drug.
Woman who has hormonal contraception.
Woman who has other diseases which is caused of abdominal pain.
Breast feeding woman
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thanyarat Wongwananuruk, MD.
Organizational Affiliation
Gynecologic Endocrinology Unit, Department of Obstetric and Gynecology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gynecologic Endocrinology Unit, Department of Obstetric and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University
City
Bangkok
ZIP/Postal Code
10700
Country
Thailand
12. IPD Sharing Statement
Links:
URL
http://www.si.mahidol.ac.th/Th/division/sirb/
Description
Siriraj Institutional Review board (SIRB)
Learn more about this trial
The Efficacy of Ayurved Siriraj Prasaplai for Treatment Primary Dysmenorrhea
We'll reach out to this number within 24 hrs